Corvus Pharmaceuticals, Inc.CRVSNASDAQ
LOADING
|||
Switch Symbol:
PB Ratio: Premium Valuation
Trending higher, above historical average.
Left:
||||
Price-to-book ratio
Latest
10.02
↑ 649% above average
Average (9y)
1.34
Historical baseline
Range
High:10.02
Low:-9.35
CAGR
NaN%
Modest growth trend
| Period | Value | Change |
|---|---|---|
| 2024 | 10.02 | +358.5% |
| 2023 | 2.18 | +209.9% |
| 2022 | 0.71 | -32.1% |
| 2021 | 1.04 | -28.6% |
| 2020 | 1.45 | -35.2% |
| 2019 | 2.25 | +145.4% |
| 2018 | 0.92 | -63.4% |
| 2017 | 2.50 | +50.7% |
| 2016 | 1.66 | +117.8% |
| 2015 | -9.35 | - |